Cannell & Spears LLC Cuts Stake in HCA Healthcare, Inc. $HCA

Cannell & Spears LLC cut its stake in HCA Healthcare, Inc. (NYSE:HCA) by 5.7% during the first quarter, HoldingsChannel reports. The institutional investor owned 40,292 shares of the company’s stock after selling 2,446 shares during the quarter. Cannell & Spears LLC’s holdings in HCA Healthcare were worth $19,068,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also made changes to their positions in the company. Nomura Asset Management Co. Ltd. boosted its position in HCA Healthcare by 6.2% during the fourth quarter. Nomura Asset Management Co. Ltd. now owns 64,237 shares of the company’s stock worth $29,990,000 after acquiring an additional 3,724 shares during the last quarter. Advisors Capital Management LLC lifted its stake in HCA Healthcare by 61.5% in the 4th quarter. Advisors Capital Management LLC now owns 6,836 shares of the company’s stock worth $3,192,000 after purchasing an additional 2,604 shares in the last quarter. Arrowstreet Capital Limited Partnership grew its position in shares of HCA Healthcare by 11.9% in the fourth quarter. Arrowstreet Capital Limited Partnership now owns 2,311,112 shares of the company’s stock valued at $1,078,966,000 after purchasing an additional 245,887 shares in the last quarter. Liberty Wealth Management LLC purchased a new position in HCA Healthcare during the fourth quarter worth approximately $1,905,000. Finally, Intech Investment Management LLC grew its holdings in HCA Healthcare by 10.0% in the 4th quarter. Intech Investment Management LLC now owns 55,273 shares of the company’s stock valued at $25,805,000 after buying an additional 5,019 shares in the last quarter. Hedge funds and other institutional investors own 62.73% of the company’s stock.

HCA Healthcare Stock Performance

NYSE:HCA opened at $382.28 on Friday. The stock has a market capitalization of $84.80 billion, a P/E ratio of 13.15, a PEG ratio of 1.27 and a beta of 1.12. HCA Healthcare, Inc. has a fifty-two week low of $330.00 and a fifty-two week high of $556.52. The company has a 50 day moving average price of $386.95 and a 200 day moving average price of $453.73.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings results on Friday, July 24th. The company reported $7.59 EPS for the quarter, topping analysts’ consensus estimates of $7.56 by $0.03. The company had revenue of $20.23 billion for the quarter, compared to analysts’ expectations of $19.76 billion. HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.The firm’s revenue was up 8.7% compared to the same quarter last year. During the same period in the prior year, the firm earned $6.84 earnings per share. Research analysts forecast that HCA Healthcare, Inc. will post 29.19 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several research analysts have recently weighed in on the stock. Leerink Partners lowered their price target on shares of HCA Healthcare from $573.00 to $500.00 and set an “outperform” rating on the stock in a research report on Monday, April 27th. Robert W. Baird decreased their target price on shares of HCA Healthcare from $450.00 to $442.00 and set a “neutral” rating on the stock in a report on Wednesday, April 15th. Wells Fargo & Company set a $369.00 price target on shares of HCA Healthcare in a report on Monday. TD Cowen lowered their price objective on HCA Healthcare from $500.00 to $431.00 and set a “buy” rating for the company in a research report on Monday, June 22nd. Finally, Sanford C. Bernstein restated a “market perform” rating on shares of HCA Healthcare in a research report on Wednesday, July 15th. Fourteen equities research analysts have rated the stock with a Buy rating, nine have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, HCA Healthcare has an average rating of “Moderate Buy” and an average price target of $483.45.

Trending Headlines about HCA Healthcare

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: HCA beat Q2 earnings estimates, reporting $7.59 per share versus expectations around $7.56-$7.57, while revenue rose 8.7% year over year to $20.23 billion and also topped estimates. HCA Healthcare earnings report
• Positive Sentiment: Management cited strong admissions and higher revenue per admission as key drivers of the quarter, suggesting healthy demand trends across its hospital network. Zacks article on HCA Q2 results
• Neutral Sentiment: HCA said its updated guidance is consistent with its earlier preview, so the quarter appears to confirm previously signaled results rather than deliver a major surprise. BusinessWire Q2 results
• Negative Sentiment: The company trimmed parts of its 2026 outlook, pointing to higher expenses and weaker surgical volumes as headwinds that could limit margin expansion. Zacks guidance revision article
• Negative Sentiment: Separate investor-law-firm investigations into HCA may add some legal overhang, though these notices are not operational results. Pomerantz investor alert

About HCA Healthcare

HCA Healthcare is a for?profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.